# Centre Hospitalier de l’Université de Montréal

**Type:** Institutions  
**Canonical URL:** https://scholariq.org/institutions/centre-hospitalier-de-l-universite-de-montreal/

## Facts

| Field | Value |
| --- | --- |
| Avg h-index | 54.2 |
| Citations | 1,803,854 |
| City | Montreal |
| Country | CA |
| Description | Centre Hospitalier de l’Université de Montréal is a research organisation in Montreal, CA. OpenAlex records 19,386 works and 1,803,854 citations for it. 4,727 researchers list it as their most recent affiliation. |
| Homepage | http://www.chumontreal.qc.ca/ |
| OpenAlex ID | https://openalex.org/I4210142730 |
| Researchers | 4,727 |
| ROR ID | https://ror.org/0410a8y51 |
| Type | healthcare |
| Works | 19,386 |

## University papers

Showing 12 of 92.

- [Intensive Blood Glucose Control and Vascular Outcomes in Patients with Type 2 Diabetes](https://scholariq.org/papers/intensive-blood-glucose-control-and-vascular-outcomes-in-patients-with-type-2/)
- [Tamoxifen for Prevention of Breast Cancer: Report of the National Surgical Adjuvant Breast and Bowel Project P-1 Study](https://scholariq.org/papers/tamoxifen-for-prevention-of-breast-cancer-report-of-the-national-surgical/)
- [Pembrolizumab alone or with chemotherapy versus cetuximab with chemotherapy for recurrent or metastatic squamous cell carcinoma of the head and neck (KEYNOTE-048): a randomised, open-label, phase 3 study](https://scholariq.org/papers/pembrolizumab-alone-or-with-chemotherapy-versus-cetuximab-with-chemotherapy-for/)
- [A genome-wide association study identifies novel risk loci for type 2 diabetes](https://scholariq.org/papers/a-genome-wide-association-study-identifies-novel-risk-loci-for-type-2-diabetes/)
- [Sentinel-lymph-node resection compared with conventional axillary-lymph-node dissection in clinically node-negative patients with breast cancer: overall survival findings from the NSABP B-32 randomised phase 3 trial](https://scholariq.org/papers/sentinel-lymph-node-resection-compared-with-conventional-axillary-lymph-node/)
- [<i>ARID1A</i> Mutations in Endometriosis-Associated Ovarian Carcinomas](https://scholariq.org/papers/i-arid1a-i-mutations-in-endometriosis-associated-ovarian-carcinomas/)
- [Pembrolizumab versus methotrexate, docetaxel, or cetuximab for recurrent or metastatic head-and-neck squamous cell carcinoma (KEYNOTE-040): a randomised, open-label, phase 3 study](https://scholariq.org/papers/pembrolizumab-versus-methotrexate-docetaxel-or-cetuximab-for-recurrent-or/)
- [Rapid Blood-Pressure Lowering in Patients with Acute Intracerebral Hemorrhage](https://scholariq.org/papers/rapid-blood-pressure-lowering-in-patients-with-acute-intracerebral-hemorrhage/)
- [Technical outcomes of sentinel-lymph-node resection and conventional axillary-lymph-node dissection in patients with clinically node-negative breast cancer: results from the NSABP B-32 randomised phase III trial](https://scholariq.org/papers/technical-outcomes-of-sentinel-lymph-node-resection-and-conventional-axillary/)
- [Albuminuria and Kidney Function Independently Predict Cardiovascular and Renal Outcomes in Diabetes](https://scholariq.org/papers/albuminuria-and-kidney-function-independently-predict-cardiovascular-and-renal/)
- [International Olympic Committee consensus statement on youth athletic development](https://scholariq.org/papers/international-olympic-committee-consensus-statement-on-youth-athletic/)
- [Treatment of Adrenocorticotropin-Dependent Cushing’s Syndrome: A Consensus Statement](https://scholariq.org/papers/treatment-of-adrenocorticotropin-dependent-cushing-s-syndrome-a-consensus/)

## University researchers

- [J. Malo](https://scholariq.org/researchers/j-malo/)
- [Marie‐France Forget](https://scholariq.org/researchers/marie-france-forget/)
- [Alexandrine Martineau](https://scholariq.org/researchers/alexandrine-martineau/)
- [Dane Christina Daoud](https://scholariq.org/researchers/dane-christina-daoud/)

## University top topics

Showing 8 of 25.

- [Prostate Cancer Treatment and Research](https://scholariq.org/topics/prostate-cancer-treatment-and-research/)
- [HIV Research and Treatment](https://scholariq.org/topics/hiv-research-and-treatment/)
- [Prostate Cancer Diagnosis and Treatment](https://scholariq.org/topics/prostate-cancer-diagnosis-and-treatment/)
- [Immune Cell Function and Interaction](https://scholariq.org/topics/immune-cell-function-and-interaction/)
- [Cancer Immunotherapy and Biomarkers](https://scholariq.org/topics/cancer-immunotherapy-and-biomarkers/)
- [Advanced Radiotherapy Techniques](https://scholariq.org/topics/advanced-radiotherapy-techniques/)
- [Opioid Use Disorder Treatment](https://scholariq.org/topics/opioid-use-disorder-treatment/)
- [T-cell and B-cell Immunology](https://scholariq.org/topics/t-cell-and-b-cell-immunology/)

---
Source: ScholarIQ — public research metadata, principally OpenAlex. See https://scholariq.org/sources/ for provenance and https://scholariq.org/methodology/ for what these figures mean.